Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Stock-Based Compensation
Abbott Laboratories
Stock-Based Compensation Peer Comparison
Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors
Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Stock-Based Compensation
$644m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Stock-Based Compensation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Stock-Based Compensation
$233m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Stock-Based Compensation
$139.4m
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
11%
|
|
Stryker Corp
NYSE:SYK
|
Stock-Based Compensation
$218m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
11%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Stock-Based Compensation
$606.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
See Also
What is Abbott Laboratories's Stock-Based Compensation?
Stock-Based Compensation
644m
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Stock-Based Compensation amounts to 644m USD.
What is Abbott Laboratories's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
10%
Over the last year, the Stock-Based Compensation growth was -3%. The average annual Stock-Based Compensation growth rates for Abbott Laboratories have been 2% over the past three years , 6% over the past five years , and 10% over the past ten years .